February's Top Rx Pharma Brands by TV Ad Spend
With $25.6 million in estimated national TV ad spend, Skyrizi was the top-spending Rx brand in February.
Skyrizi, an AbbVie immunology drug, was the No. 1 prescription pharmaceutical brand when it came to estimated national TV ad spend in February, according to iSpot.tv data shared with FiercePharma. It spent about $25.6 million on TV ads, a $12 million decrease from January's outlay of $37.7 million.
Some additional insights around TV ads from the top pharma brands in February:
- In total, the top ten brands spent about $151.6 million, a nearly 27% decrease from January's $207.4 million.
- Rinvoq, which was the top-spending Rx brand in January, took second place in February with an estimated national TV ad spend of $24.8 million, down from its January outlay of $41.3 million.
- Brands that did not make the top ten in January but did in February include Sotyktu, Paxlovid and Caplyta
